Neximmune Net Receivables vs Net Debt Analysis
| NEXI Stock | USD 3.32 0.20 6.41% |
Neximmune financial indicator trend analysis is infinitely more than just investigating Neximmune recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neximmune is a good investment. Please check the relationship between Neximmune Net Receivables and its Net Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
Net Receivables vs Net Debt
Net Receivables vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neximmune Net Receivables account and Net Debt. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Neximmune's Net Receivables and Net Debt is -0.7. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Net Debt in the same time period over historical financial statements of Neximmune, assuming nothing else is changed. The correlation between historical values of Neximmune's Net Receivables and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Neximmune are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Net Receivables i.e., Neximmune's Net Receivables and Net Debt go up and down completely randomly.
Correlation Coefficient | -0.7 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Net Receivables
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Neximmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neximmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.As of now, Neximmune's Selling General Administrative is increasing as compared to previous years. The Neximmune's current Enterprise Value Over EBITDA is estimated to increase to 0.03, while Issuance Of Capital Stock is projected to decrease to 0.00.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 861.4K | 576.7K | 1.0M | 702.8K | Interest Income | 52.5K | 664.4K | 973.3K | 1.0M |
Neximmune fundamental ratios Correlations
Click cells to compare fundamentals
Neximmune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neximmune fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
| Other Current Liab | 1.9M | 2.5M | 6.2M | 7.4M | 3.7B | 3.9B | |
| Total Current Liabilities | 3.0M | 27.0M | 7.2M | 10.3M | 5.1M | 4.8M | |
| Total Stockholder Equity | 10.6M | (15.8M) | 83.8M | 32.3M | 3.5M | 3.3M | |
| Net Tangible Assets | (43.0M) | (69.4M) | 83.8M | 32.3M | 37.1M | 39.0M | |
| Property Plant And Equipment Net | 2.6M | 2.9M | 4.4M | 5.4M | 1.4M | 1.3M | |
| Net Debt | 44.5M | 14.1M | (30.3M) | (33.6M) | (3.1M) | (3.0M) | |
| Retained Earnings | (47.7M) | (77.6M) | (127.7M) | (190.2M) | (222.6M) | (211.5M) | |
| Accounts Payable | 1.2M | 2.8M | 1.0M | 2.4M | 1.3M | 1.8M | |
| Cash | 9.1M | 5.0M | 30.3M | 34.6M | 3.2M | 3.0M | |
| Non Current Assets Total | 2.7M | 2.9M | 4.8M | 5.7M | 3.2M | 3.9M | |
| Non Currrent Assets Other | 103.6K | 23.4K | 324.1K | 265.0K | 1.8M | 1.9M | |
| Cash And Short Term Investments | 10.1M | 5.0M | 81.8M | 34.6M | 4.6M | 4.4M | |
| Common Stock Shares Outstanding | 900.9K | 910.3K | 913.2K | 962.4K | 1.0M | 1.9M | |
| Liabilities And Stockholders Equity | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
| Other Current Assets | 833.2K | 78.5K | 99.2K | 2.7M | 215.2K | 204.5K | |
| Other Stockholder Equity | 4.7M | 8.2M | (90.8B) | 222.5M | 226.1M | 237.4M | |
| Total Liab | 3.1M | 27.1M | 7.3M | 10.8M | 5.1M | 4.8M | |
| Net Invested Capital | (43.0M) | (50.3M) | 83.8M | 32.3M | 3.5M | 3.7M | |
| Property Plant And Equipment Gross | 2.6M | 2.9M | 6.7M | 5.4M | 3.0M | 4.1M | |
| Total Current Assets | 11.0M | 8.4M | 86.3M | 37.4M | 5.4M | 5.1M | |
| Net Working Capital | 8.0M | (18.6M) | 79.1M | 27.0M | 316.7K | 300.9K | |
| Property Plant Equipment | 2.6M | 2.9M | 4.4M | 5.4M | 6.2M | 3.7M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neximmune in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neximmune's short interest history, or implied volatility extrapolated from Neximmune options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Neximmune Stock analysis
When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (30.82) | Return On Assets (0.71) | Return On Equity (1.81) |
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.